Literature DB >> 480857

[Biochemical research in depression (author's transl)].

O Benkert.   

Abstract

The biochemical research of depression did not gain in before the exploration of the nodes of effect of the antidepressants. For the present the point of research was the search for disturbances in metabolism of the biogenic amines in brain. The noradrenalin and serotonin-hypothesis was propounded postulating a disturbance in noradrenalin, or serotonin regulation, respectively at the receptor in depression. Until now experimental results did not support this hypothesis, just as the investigations of electrolytic changes in depression did not lead to homogeneous results. On the contrary the neuroendocrinological research showed important results; In endogenous depressive patients an increased cortisol-secretion was ascertained, and in about 65% of the patients a missing or strongly reduced cortisol-suppression after injection of dexamethason was noted, moreover, the growth-hormone-secretion after insulin-hypoglycemia is reduced in a part of depressive women in the menopause. Finally the thyrotropin-secretion stopped in 20--40% of the endogenous depressive patients after injection of thyrotropin-releasing hormone.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 480857     DOI: 10.1007/bf01477665

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  37 in total

1.  [Treatment of depressive states with an iminodibenzyl derivative (G 22355)].

Authors:  R KUHN
Journal:  Schweiz Med Wochenschr       Date:  1957-08-31

2.  Letter: Comparison of T.R.H., L.H.-R.H., and placebo in depression.

Authors:  O Benkert; D Martschke; A Gordon
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

3.  Total and free tryptophan concentration in the plasma of depressive patients.

Authors:  A Coppen; E G Eccleston; M Peet
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

4.  L-dopa plus decarboxylase inhibitor in depression.

Authors:  N Matussek; O Benkert; K Schneider; H Otten; H Pohlmeier
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

5.  The efficacy of antidepressant drugs. A review of research (1958-1972).

Authors:  J B Morris; A T Beck
Journal:  Arch Gen Psychiatry       Date:  1974-05

Review 6.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

7.  Excretion of catecholamine metabolites following intraventricular injection of 6-hydroxydopamine in the Macaca speciosa.

Authors:  J W Maas; H Dekirmenjian; D Garver; D E Redmond; D H Landis
Journal:  Eur J Pharmacol       Date:  1973-08       Impact factor: 4.432

8.  Effect of clonidine on growth hormone release in psychiatric patients and controls.

Authors:  N Matussek; M Ackenheil; H Hippius; F Müller; H T Schröder; H Schultes; B Wasilewski
Journal:  Psychiatry Res       Date:  1980-03       Impact factor: 3.222

9.  Effect of zimelidine (H 102/09) in depressive patients.

Authors:  O Benkert; G Laakmann; L Ott; A Strauss; R Zimmer
Journal:  Arzneimittelforschung       Date:  1977

10.  Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients.

Authors:  B Shopsin; E Friedman; S Gershon
Journal:  Arch Gen Psychiatry       Date:  1976-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.